An introduction to the US National Labs incl. the National Institute of Health (NIH) and why they can be attractive partners for emerging companies
The US National Laboratories are a network of research institutions across the United States, collectively managed by the Department of Energy (DOE), Department of Defense (DOD), and other government agencies. They conduct cutting-edge research and development in areas such as energy, national security, and health. These laboratories are staffed by scientists and engineers who work collaboratively with academia, industry, and government to solve some of the most complex challenges facing society. Partnering with national labs can accelerate research and development efforts, provide funding and mentorship opportunities, and offer access to e.g. high-throughput screening technologies, genomics, proteomics, and bioinformatics expertise for drug discovery and development.
The National Institutes of Health (NIH) is one of the largest biomedical research institutions in the world. The NIH also offers a range of collaborative opportunities for industry partners such as access to cutting-edge technology, research tools, and scientific expertise. Through collaborations with the NIH, industry partners can accelerate their research and development efforts, gain a competitive edge, and speed up the development of innovative products and therapies. Partnering with national labs can be a strategic move for companies looking to bring their products to market more effectively.
In this webinar you will learn:
- About the NIH as a Technology Development and Commercialization Partner
- The US National Laboratory Landscape and how to collaborate with Federal Labs
- The NIH and other National labs as resources companies should consider to bolster their pipeline or solve a development problem
- Why industry partnerships are mutually beneficial for companies and the NIH and National Labs
- About success stories and partnership examples
- Whom to contact and which partnering mechanisms are used
Tentative Agenda (timeslots and talk titles tbc)
15.00 – Welcome and Introduction (Hanne Mette Kristensen, CEO, The Life Science Cluster)
15.05 – National Institutes of Health (NIH): a collaboration partner for Norwegian companies within drugs, diagnostics, medtech and e-health
Michael L. Salgaller, Ph.D., Supervisor, Technology Analysis and Marketing Unit (TAMU), Technology Transfer Center, National Cancer Institute, National Institutes of Health
15.20 – The role of the NIH TTO in finding and establishing collaboration
Steven M. Ferguson, CLP, Special Advisor, NIH Office of Technology Transfer
15.35 – An overview of the US Federal labs – opportunities for collaboration
Paul Zielinski MS,MBA, Executive Director, Federal Laboratory Consortium for Technology Transfer (FLC)
15.50 – Q&A
For more information, please contact Jutta Heix, Head of International Affairs, Oslo Cancer Cluster.
In cooperation with Viken fylkeskommune, The Life Science Cluster, Norwegian Smart Care Cluster and Oslo Cancer Cluster.